A quantitative neuromotor predictor of antidepressant non-response in patients with major depression

Journal of Affective Disorders

Volumn 77, Issue 2, 2003, Pages 135-141

  Caligiuri, Michael P ^a,b   Gentili, Valentina ^a   Eberson, Sonja ^a   Kelsoe, John ^a   Rapaport, Mark ^a   Gillin, J Christian ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antidepressant response; Clinical trials; Parkinsonism; Psychomotor retardation

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; PHENELZINE; SERTRALINE;

ADULT; ARTICLE; BRADYKINESIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; FEMALE; HUMAN; MALE; MOTOR RETARDATION; PREDICTION; PRIORITY JOURNAL; PSYCHOMETRY; PSYCHOMOTOR ACTIVITY; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT FAILURE;

EID: 0242329800     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(02)00107-6     Document Type: Article

References (15)

1. Berman R.M., Narasimham M., Charney D.C. Treatment - refactory depression: definitions and characteristics. Depress. Anxiety. 5:1997;154-164.
2. Bruder G.E., Tenke C.E., Stewart J.W., McGrath P.J., Quitkin F.M. Predictors of therapeutic response to treatments for depression: a review of electrophysiologic and dichotic listening studies. CNS Spectrums. 4:1999;30-36.
3. Caligiuri M.P., Ellwanger J. Motor and cognitive aspects of motor retardation in depression. J. Affect. Disord. 57:2000;83-93.
4. Caligiuri M.P., Lohr J.B., Ruck R. Scaling of movement velocity: A measure of neuromotor retardation in individuals with psychopathology. Psychophysiology. 35:1998;431-437.
5. Dantchev N., Widlöcher D.J. The measurement of retardation in depression. J Clin. Psychiatry. 59:(Suppl 14):1998;19-25.
6. Flament M.F., Lane R.M., Zhu R., Ying Z. Predictors of an acute antidepressant response to fluoxetine and sertraline. Int. Clin. Psychopharmacol. 14:1999;259-275.
7. Frank E., Prein R.F., Jarrett R.B., Keller M.B., Kupfer D.J., Lavori P.W., Rush J., Weissmen M.M. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence. Arch. Gen. Psychiatry. 48:1991;851-855.
8. Maes M., Meltzer H.Y. The serotonin hypothesis of major depression. Bloom F.E., Kupfer D.J. Psychopharmacology: The Fourth Generation of Progress. 1995;933-944 Raven Press.
9. Nelson J.C. A review of the efficacy of serotonergic and noradrenergic reuptake inhibitors for treatment of major depression. Biol. Psychiatry. 46:1999;301-308.
10. Othmer E., Othmer J.P., Othmer S.C. Brain functions and psychiatric disorders: a clinical view. The Psychiatric Clinics of North America. 21:1998;517-566.
11. Simpson S., Baldwin R.C., Jackson A., Burns A.S. Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroradiological findings in late-life depression. Psychol. Med. 28:1998;1015-1026.
12. Sobin C., Sackeim H.A. Psychomotor symptoms of depression. Am. J. Psychiatry. 154:(1):1997;4-17.
13. Stahl S.M. Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 1996;Cambridge University Press, Cambridge.
14. Stewart J.W., Quitkin F.M., McGrath P.J., Bruder G.E. Do tricyclic responders have different brain laterality? J. Abnormal Psychol. 108:(4):1999;707-710.
15. Swann A.C., Katz M.M., Bowen C.L., Berman N.G., Stokes P.E. Psychomotor performance and monoamine function in bipolar and unipolar affective disorders. Biol. Psychiatry. 45:1999;979-988.